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Z-CAN: prevention of unintended pregnancy in an
emergency setting
Prevention of unintended pregnancy is a primary
strategy to reduce adverse pregnancy and birth
outcomes related to Zika virus infection. Infection
during pregnancy, either through a mosquito bite
or sex with an infected partner, increases the risk of
the child developing congenital microcephaly and
other fetal brain abnormalities, resulting in the birth
of a child with severe disabilities that will necessitate
lifelong care.1,2
Zika virus infection is still a reproductive health
issue for women living in the southern part of North
America and in South America because of limited
contraceptive choices and lack of knowledge of longacting contraceptives (LARC).2 Effective interventions
are well known and recommended by WHO. These
include access to contraceptives and reducing
barriers to obtaining contraception for women and
girls, as well as providing health-care workers with
evidence-based information about the Zika virus and
contraceptive options.3
In some countries, governments responded to the
2016–17 Zika virus outbreak by issuing recommendations
to avoid mosquito bites but made no family planning
initiatives to assist women in preventing pregnancy.2
Puerto Rico, which saw the highest numbers of Zika virus
infections in the USA in 2016,4 has set an example of
initiatives to improve access to contraception.
In The Lancet Public Health, Eva Lathrop and
colleagues5 describe the Zika Contraception Access
Network (Z-CAN) programme in Puerto Rico. Using
technical expertise from the US Centers for Disease
Control and Prevention (CDC), and in collaboration
with a diverse group of stakeholders and private
donors, the goal of Z-CAN was to create a simple but
effective process to educate health-care providers on
the use and application of modern contraceptives
and to provide free contraception services to women
attending the Z-CAN clinics who chose to prevent
pregnancy during the 2016–17 Zika virus outbreak.
This goal was accomplished in two stages. The first
stage consisted of a 1-day training course for healthcare providers at established health-care centres in
Puerto Rico. The course offered an overview of the

Zika virus and the importance of condoms, a clientcentred contraceptive counselling curriculum, a review
of evidence-based information on contraceptives
(including the full range of reversible contraceptives
available, practical training on the insertion and
removal of intrauterine devices, and FDA-approved
etonogestrel implants), and an overview of the Z-CAN
programme goals and policies.3,4 For the second stage,
private donors and stakeholders provided funding to
cover the cost of the contraception of choice for all
women attending the 139 Z-CAN clinics.
153 providers were trained in the Z-CAN programme.
20 110 (95%) of the 21 124 women attending the
Z-CAN clinics received the contraception of their choice
at their first appointment, and 14 259 (68%) women
chose a LARC. Most of the women who completed a
satisfaction survey after their visit were very satisfied
with the services provided. The programme and
implementation are in line with current CDC and
WHO recommendations for combatting the Zika virus
outbreak.6–8 Since the programme has proved effective,
it could be duplicated in other areas that are affected by
the Zika virus outbreak.3,5
It is impressive that a simple intervention can have
such a high impact. The devastating effects of the Zika
virus outbreak were surely compelling the women
to choose contraception at this point in time, and
the question that remains is whether the outcomes
of Z-CAN are due to the immediate and highly
visible effects of Zika virus infection on the infant or
are correlated to the better quality of care and free
services provided by Z-CAN. Surely it was easier to
raise funds for contraceptives from private donors and
stakeholders during the emergency situation than it
would have been during a non-emergency situation.
Nevertheless, this short-term response model for rapid
implementation deserves high visibility and should be
scaled up and rolled out. Perhaps we can learn lessons
from the emergency response to the 2016–17 Zika virus
outbreak and test a similar model of short, evidencebased training of health-care providers combined with
increased availability of contraceptive methods in nonemergency settings.
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